Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 330 entries
Sorted by: Best Match Show Resources per page
A Novel Device for Grasping Assessment during Functional Tasks: Preliminary Results.

Frontiers in bioengineering and biotechnology

Rocha AC, Tudella E, Pedro LM, Appel VC, da Silva LG, Caurin GA.
PMID: 26942178
Front Bioeng Biotechnol. 2016 Feb 22;4:16. doi: 10.3389/fbioe.2016.00016. eCollection 2016.

This paper presents a methodology and first results obtained in a study with a novel device that allows the analysis of grasping quality. Such a device is able to acquire motion information of upper limbs allowing kinetic of manipulation...

Cite
Rocha AC, Tudella E, Pedro LM, et al. A Novel Device for Grasping Assessment during Functional Tasks: Preliminary Results. Front Bioeng Biotechnol. 2016;4:16doi: 10.3389/fbioe.2016.00016.
Rocha, A. C., Tudella, E., Pedro, L. M., Appel, V. C., da Silva, L. G., & Caurin, G. A. (2016). A Novel Device for Grasping Assessment during Functional Tasks: Preliminary Results. Frontiers in bioengineering and biotechnology, 416. https://doi.org/10.3389/fbioe.2016.00016
Rocha, Ana Carolinne Portela, et al. "A Novel Device for Grasping Assessment during Functional Tasks: Preliminary Results." Frontiers in bioengineering and biotechnology vol. 4 (2016): 16. doi: https://doi.org/10.3389/fbioe.2016.00016
Rocha AC, Tudella E, Pedro LM, Appel VC, da Silva LG, Caurin GA. A Novel Device for Grasping Assessment during Functional Tasks: Preliminary Results. Front Bioeng Biotechnol. 2016 Feb 22;4:16. doi: 10.3389/fbioe.2016.00016. eCollection 2016. PMID: 26942178; PMCID: PMC4761859.
Copy Download .nbib Format: NLM
Complete Genome Sequence of Herbaspirillum hiltneri N3 (DSM 17495), Isolated from Surface-Sterilized Wheat Roots.

Genome announcements

Guizelini D, Saizaki PM, Coimbra NA, Weiss VA, Faoro H, Sfeir MZ, Baura VA, Monteiro RA, Chubatsu LS, Souza EM, Cruz LM, Pedrosa FO, Raittz RT, Marchaukoski JN, Steffens MB.
PMID: 26514770
Genome Announc. 2015 Oct 29;3(5). doi: 10.1128/genomeA.01288-15.

We report the complete genome sequence of Herbaspirillum hiltneri N3 (DSM 17495), a member of the genus Herbaspirillum of the Betaproteobacteria. The genome is contained in a single chromosome, and analysis revealed that N3 lacks the whole nitrogen fixation...

Cite
Guizelini D, Saizaki PM, Coimbra NA, et al. Complete Genome Sequence of Herbaspirillum hiltneri N3 (DSM 17495), Isolated from Surface-Sterilized Wheat Roots. Genome Announc. 2015;3(5)doi: 10.1128/genomeA.01288-15.
Guizelini, D., Saizaki, P. M., Coimbra, N. A., Weiss, V. A., Faoro, H., Sfeir, M. Z., Baura, V. A., Monteiro, R. A., Chubatsu, L. S., Souza, E. M., Cruz, L. M., Pedrosa, F. O., Raittz, R. T., Marchaukoski, J. N., & Steffens, M. B. (2015). Complete Genome Sequence of Herbaspirillum hiltneri N3 (DSM 17495), Isolated from Surface-Sterilized Wheat Roots. Genome announcements, 3(5), . https://doi.org/10.1128/genomeA.01288-15
Guizelini, Dieval, et al. "Complete Genome Sequence of Herbaspirillum hiltneri N3 (DSM 17495), Isolated from Surface-Sterilized Wheat Roots." Genome announcements vol. 3,5 (2015). doi: https://doi.org/10.1128/genomeA.01288-15
Guizelini D, Saizaki PM, Coimbra NA, Weiss VA, Faoro H, Sfeir MZ, Baura VA, Monteiro RA, Chubatsu LS, Souza EM, Cruz LM, Pedrosa FO, Raittz RT, Marchaukoski JN, Steffens MB. Complete Genome Sequence of Herbaspirillum hiltneri N3 (DSM 17495), Isolated from Surface-Sterilized Wheat Roots. Genome Announc. 2015 Oct 29;3(5). doi: 10.1128/genomeA.01288-15. PMID: 26514770; PMCID: PMC4626616.
Copy Download .nbib Format: NLM
Small-Gauge Pars Plana Vitrectomy for the Management of Symptomatic Posterior Vitreous Detachment after Phacoemulsification and Multifocal Intraocular Lens Implantation: A Pilot Study from the Pan-American Collaborative Retina Study Group.

Journal of ophthalmology

Navarro RM, Machado LM, Maia O, Wu L, Farah ME, Magalhaes O, Arevalo JF, Maia M.
PMID: 26504590
J Ophthalmol. 2015;2015:156910. doi: 10.1155/2015/156910. Epub 2015 Oct 04.

Purpose. To determine the efficacy of 23-gauge pars plana vitrectomy (PPV) for symptomatic posterior vitreous detachment (PVD) on visual acuity (VA) and quality after multifocal intraocular lenses (IOLs). Methods. In this prospective case series, patients who developed symptomatic PVD...

Cite
Navarro RM, Machado LM, Maia O, et al. Small-Gauge Pars Plana Vitrectomy for the Management of Symptomatic Posterior Vitreous Detachment after Phacoemulsification and Multifocal Intraocular Lens Implantation: A Pilot Study from the Pan-American Collaborative Retina Study Group. J Ophthalmol. 2015;2015:156910doi: 10.1155/2015/156910.
Navarro, R. M., Machado, L. M., Maia, O., Wu, L., Farah, M. E., Magalhaes, O., Arevalo, J. F., & Maia, M. (2015). Small-Gauge Pars Plana Vitrectomy for the Management of Symptomatic Posterior Vitreous Detachment after Phacoemulsification and Multifocal Intraocular Lens Implantation: A Pilot Study from the Pan-American Collaborative Retina Study Group. Journal of ophthalmology, 2015156910. https://doi.org/10.1155/2015/156910
Navarro, Rodrigo M, et al. "Small-Gauge Pars Plana Vitrectomy for the Management of Symptomatic Posterior Vitreous Detachment after Phacoemulsification and Multifocal Intraocular Lens Implantation: A Pilot Study from the Pan-American Collaborative Retina Study Group." Journal of ophthalmology vol. 2015 (2015): 156910. doi: https://doi.org/10.1155/2015/156910
Navarro RM, Machado LM, Maia O, Wu L, Farah ME, Magalhaes O, Arevalo JF, Maia M. Small-Gauge Pars Plana Vitrectomy for the Management of Symptomatic Posterior Vitreous Detachment after Phacoemulsification and Multifocal Intraocular Lens Implantation: A Pilot Study from the Pan-American Collaborative Retina Study Group. J Ophthalmol. 2015;2015:156910. doi: 10.1155/2015/156910. Epub 2015 Oct 04. PMID: 26504590; PMCID: PMC4609434.
Copy Download .nbib Format: NLM
In Situ GIWAXS Analysis of Solvent and Additive Effects on PTB7 Thin Film Microstructure Evolution during Spin Coating.

Advanced materials (Deerfield Beach, Fla.)

Manley EF, Strzalka J, Fauvell TJ, Jackson NE, Leonardi MJ, Eastham ND, Marks TJ, Chen LX.
PMID: 28990271
Adv Mater. 2017 Nov;29(43). doi: 10.1002/adma.201703933. Epub 2017 Oct 09.

The influence of solvent and processing additives on the pathways and rates of crystalline morphology formation for spin-coated semiconducting PTB7 (poly[[4,8-bis[(2-ethylhexyl)oxy]benzo[1,2-b:4,5-b']dithiophene-2,6-diyl][3-fluoro-2-[(2-ethylhexyl)-carbonyl]-thieno[3,4-b]thiophenediyl]]) thin films is investigated by in situ grazing incidence wide-angle X-ray scattering (GIWAXS) and optical reflectance, to better...

Cite
Manley EF, Strzalka J, Fauvell TJ, et al. In Situ GIWAXS Analysis of Solvent and Additive Effects on PTB7 Thin Film Microstructure Evolution during Spin Coating. Adv Mater. 2017;29(43)doi: 10.1002/adma.201703933.
Manley, E. F., Strzalka, J., Fauvell, T. J., Jackson, N. E., Leonardi, M. J., Eastham, N. D., Marks, T. J., & Chen, L. X. (2017). In Situ GIWAXS Analysis of Solvent and Additive Effects on PTB7 Thin Film Microstructure Evolution during Spin Coating. Advanced materials (Deerfield Beach, Fla.), 29(43), . https://doi.org/10.1002/adma.201703933
Manley, Eric F, et al. "In Situ GIWAXS Analysis of Solvent and Additive Effects on PTB7 Thin Film Microstructure Evolution during Spin Coating." Advanced materials (Deerfield Beach, Fla.) vol. 29,43 (2017). doi: https://doi.org/10.1002/adma.201703933
Manley EF, Strzalka J, Fauvell TJ, Jackson NE, Leonardi MJ, Eastham ND, Marks TJ, Chen LX. In Situ GIWAXS Analysis of Solvent and Additive Effects on PTB7 Thin Film Microstructure Evolution during Spin Coating. Adv Mater. 2017 Nov;29(43). doi: 10.1002/adma.201703933. Epub 2017 Oct 09. PMID: 28990271.
Copy Download .nbib Format: NLM
Clinical Effectiveness and Safety of Analog Glargine in Type 1 Diabetes: A Systematic Review and Meta-Analysis.

Diabetes therapy : research, treatment and education of diabetes and related disorders

Marra LP, Araújo VE, Silva TB, Diniz LM, Guerra Junior AA, Acurcio FA, Godman B, Álvares J.
PMID: 27048292
Diabetes Ther. 2016 Jun;7(2):241-58. doi: 10.1007/s13300-016-0166-y. Epub 2016 Apr 05.

INTRODUCTION: The use of insulin analogs for the treatment of type 1 diabetes mellitus (T1DM) is widespread; however, the therapeutic benefits still require further evaluation given their higher costs. The objective of this study was to evaluate the effectiveness...

Cite
Marra LP, Araújo VE, Silva TB, et al. Clinical Effectiveness and Safety of Analog Glargine in Type 1 Diabetes: A Systematic Review and Meta-Analysis. Diabetes Ther. 2016;7(2):241-58doi: 10.1007/s13300-016-0166-y.
Marra, L. P., Araújo, V. E., Silva, T. B., Diniz, L. M., Guerra Junior, A. A., Acurcio, F. A., Godman, B., & Álvares, J. (2016). Clinical Effectiveness and Safety of Analog Glargine in Type 1 Diabetes: A Systematic Review and Meta-Analysis. Diabetes therapy : research, treatment and education of diabetes and related disorders, 7(2), 241-58. https://doi.org/10.1007/s13300-016-0166-y
Marra, Lays P, et al. "Clinical Effectiveness and Safety of Analog Glargine in Type 1 Diabetes: A Systematic Review and Meta-Analysis." Diabetes therapy : research, treatment and education of diabetes and related disorders vol. 7,2 (2016): 241-58. doi: https://doi.org/10.1007/s13300-016-0166-y
Marra LP, Araújo VE, Silva TB, Diniz LM, Guerra Junior AA, Acurcio FA, Godman B, Álvares J. Clinical Effectiveness and Safety of Analog Glargine in Type 1 Diabetes: A Systematic Review and Meta-Analysis. Diabetes Ther. 2016 Jun;7(2):241-58. doi: 10.1007/s13300-016-0166-y. Epub 2016 Apr 05. PMID: 27048292; PMCID: PMC4900976.
Copy Download .nbib Format: NLM
Unifying Evaluation of the Technical Performances of Iron-Tetra-amido Macrocyclic Ligand Oxidation Catalysts.

Journal of the American Chemical Society

DeNardo MA, Mills MR, Ryabov AD, Collins TJ.
PMID: 26886296
J Am Chem Soc. 2016 Mar 09;138(9):2933-6. doi: 10.1021/jacs.5b13087. Epub 2016 Feb 24.

The main features of iron-tetra-amido macrocyclic ligand complex (a sub-branch of TAML) catalysis of peroxide oxidations are rationalized by a two-step mechanism: Fe(III) + H2O2 → Active catalyst (Ac) (kI), and Ac + Substrate (S) → Fe(III) + Product...

Cite
DeNardo MA, Mills MR, Ryabov AD, et al. Unifying Evaluation of the Technical Performances of Iron-Tetra-amido Macrocyclic Ligand Oxidation Catalysts. J Am Chem Soc. 2016;138(9):2933-6doi: 10.1021/jacs.5b13087.
DeNardo, M. A., Mills, M. R., Ryabov, A. D., & Collins, T. J. (2016). Unifying Evaluation of the Technical Performances of Iron-Tetra-amido Macrocyclic Ligand Oxidation Catalysts. Journal of the American Chemical Society, 138(9), 2933-6. https://doi.org/10.1021/jacs.5b13087
DeNardo, Matthew A, et al. "Unifying Evaluation of the Technical Performances of Iron-Tetra-amido Macrocyclic Ligand Oxidation Catalysts." Journal of the American Chemical Society vol. 138,9 (2016): 2933-6. doi: https://doi.org/10.1021/jacs.5b13087
DeNardo MA, Mills MR, Ryabov AD, Collins TJ. Unifying Evaluation of the Technical Performances of Iron-Tetra-amido Macrocyclic Ligand Oxidation Catalysts. J Am Chem Soc. 2016 Mar 09;138(9):2933-6. doi: 10.1021/jacs.5b13087. Epub 2016 Feb 24. PMID: 26886296.
Copy Download .nbib Format: NLM
Draft Genome Sequence of Aeromonas caviae 8LM, Isolated from Stool Culture of a Child with Diarrhea.

Genome announcements

Moriel B, Cruz LM, Dallagassa CB, Faoro H, de Souza EM, Pedrosa FO, Rego FG, Picheth G, Fadel-Picheth CM.
PMID: 25999559
Genome Announc. 2015 May 21;3(3). doi: 10.1128/genomeA.00524-15.

Aeromonas spp. are Gram-negative rods ubiquitous in aquatic environments; however, some species are able to cause a variety of infections in humans. Here, we report the draft genome sequence of Aeromonas caviae 8LM isolated from stool culture from a...

Cite
Moriel B, Cruz LM, Dallagassa CB, et al. Draft Genome Sequence of Aeromonas caviae 8LM, Isolated from Stool Culture of a Child with Diarrhea. Genome Announc. 2015;3(3)doi: 10.1128/genomeA.00524-15.
Moriel, B., Cruz, L. M., Dallagassa, C. B., Faoro, H., de Souza, E. M., Pedrosa, F. O., Rego, F. G., Picheth, G., & Fadel-Picheth, C. M. (2015). Draft Genome Sequence of Aeromonas caviae 8LM, Isolated from Stool Culture of a Child with Diarrhea. Genome announcements, 3(3), . https://doi.org/10.1128/genomeA.00524-15
Moriel, Bárbara, et al. "Draft Genome Sequence of Aeromonas caviae 8LM, Isolated from Stool Culture of a Child with Diarrhea." Genome announcements vol. 3,3 (2015). doi: https://doi.org/10.1128/genomeA.00524-15
Moriel B, Cruz LM, Dallagassa CB, Faoro H, de Souza EM, Pedrosa FO, Rego FG, Picheth G, Fadel-Picheth CM. Draft Genome Sequence of Aeromonas caviae 8LM, Isolated from Stool Culture of a Child with Diarrhea. Genome Announc. 2015 May 21;3(3). doi: 10.1128/genomeA.00524-15. PMID: 25999559; PMCID: PMC4440973.
Copy Download .nbib Format: NLM
Incorporating Quality into Data Envelopment Analysis of Nursing Home Performance: A Case Study.

Omega

Shimshak DG, Lenard ML, Klimberg RK.
PMID: 20161166
Omega. 2009 Jun 01;37(3):672-685. doi: 10.1016/j.omega.2008.05.004.

When using data envelopment analysis (DEA) as a benchmarking technique for nursing homes, it is essential to include measures of the quality of care. We survey applications where quality has been incorporated into DEA models and consider the concerns...

Cite
Shimshak DG, Lenard ML, Klimberg RK. Incorporating Quality into Data Envelopment Analysis of Nursing Home Performance: A Case Study. Omega. 2009;37(3):672-685doi: 10.1016/j.omega.2008.05.004.
Shimshak, D. G., Lenard, M. L., & Klimberg, R. K. (2009). Incorporating Quality into Data Envelopment Analysis of Nursing Home Performance: A Case Study. Omega, 37(3), 672-685. https://doi.org/10.1016/j.omega.2008.05.004
Shimshak, Daniel G, et al. "Incorporating Quality into Data Envelopment Analysis of Nursing Home Performance: A Case Study." Omega vol. 37,3 (2009): 672-685. doi: https://doi.org/10.1016/j.omega.2008.05.004
Shimshak DG, Lenard ML, Klimberg RK. Incorporating Quality into Data Envelopment Analysis of Nursing Home Performance: A Case Study. Omega. 2009 Jun 01;37(3):672-685. doi: 10.1016/j.omega.2008.05.004. PMID: 20161166; PMCID: PMC2720542.
Copy Download .nbib Format: NLM
The role of thalidomide in the treatment of rheumatic disease.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases

Lenardo TM, Calabrese LH.
PMID: 19078444
J Clin Rheumatol. 2000 Feb;6(1):19-26. doi: 10.1097/00124743-200002000-00003.

Thalidomide was first introduced in 1956 as a sedative hypnotic in Europe and Asia but was soon withdrawn from the market because of its association with severe birth defects. It has experienced a resurgence of interest in recent years...

Cite
Lenardo TM, Calabrese LH. The role of thalidomide in the treatment of rheumatic disease. J Clin Rheumatol. 2000;6(1):19-26doi: 10.1097/00124743-200002000-00003.
Lenardo, T. M., & Calabrese, L. H. (2000). The role of thalidomide in the treatment of rheumatic disease. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 6(1), 19-26. https://doi.org/10.1097/00124743-200002000-00003
Lenardo, T M, and Calabrese, L H. "The role of thalidomide in the treatment of rheumatic disease." Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases vol. 6,1 (2000): 19-26. doi: https://doi.org/10.1097/00124743-200002000-00003
Lenardo TM, Calabrese LH. The role of thalidomide in the treatment of rheumatic disease. J Clin Rheumatol. 2000 Feb;6(1):19-26. doi: 10.1097/00124743-200002000-00003. PMID: 19078444.
Copy Download .nbib Format: NLM
Treatment of chronic obstructive pulmonary disease and its comorbidities.

Proceedings of the American Thoracic Society

Luppi F, Franco F, Beghé B, Fabbri LM.
PMID: 19017740
Proc Am Thorac Soc. 2008 Dec 01;5(8):848-56. doi: 10.1513/pats.200809-101TH.

While chronic obstructive pulmonary disease (COPD) is still characterized and diagnosed by lung function measurements, there is increasing evidence that the chronic diseases that frequently develop with COPD in response to the common risk factors (smoking, aging, obesity) may...

Cite
Luppi F, Franco F, Beghé B, et al. Treatment of chronic obstructive pulmonary disease and its comorbidities. Proc Am Thorac Soc. 2008;5(8):848-56doi: 10.1513/pats.200809-101TH.
Luppi, F., Franco, F., Beghé, B., & Fabbri, L. M. (2008). Treatment of chronic obstructive pulmonary disease and its comorbidities. Proceedings of the American Thoracic Society, 5(8), 848-56. https://doi.org/10.1513/pats.200809-101TH
Luppi, Fabrizio, et al. "Treatment of chronic obstructive pulmonary disease and its comorbidities." Proceedings of the American Thoracic Society vol. 5,8 (2008): 848-56. doi: https://doi.org/10.1513/pats.200809-101TH
Luppi F, Franco F, Beghé B, Fabbri LM. Treatment of chronic obstructive pulmonary disease and its comorbidities. Proc Am Thorac Soc. 2008 Dec 01;5(8):848-56. doi: 10.1513/pats.200809-101TH. PMID: 19017740.
Copy Download .nbib Format: NLM
Trends over time in the management of 2253 patients with cerebral aneurysms: A single practice experience.

Surgical neurology international

Payner TD, Melamed I, Ansari S, Leipzig TJ, Scott JA, Denardo AJ, Horner TG, Redelman K, Cohen-Gadol AA.
PMID: 21886883
Surg Neurol Int. 2011;2:110. doi: 10.4103/2152-7806.83728. Epub 2011 Aug 13.

BACKGROUND: To better understand the longitudinal trend in the proportion of techniques employed for cerebral aneurysm treatment, we reviewed our experience with 2253 patients over the last 11 years.METHODS: We reviewed data in our prospective aneurysm database for all...

Cite
Payner TD, Melamed I, Ansari S, et al. Trends over time in the management of 2253 patients with cerebral aneurysms: A single practice experience. Surg Neurol Int. 2011;2:110doi: 10.4103/2152-7806.83728.
Payner, T. D., Melamed, I., Ansari, S., Leipzig, T. J., Scott, J. A., Denardo, A. J., Horner, T. G., Redelman, K., & Cohen-Gadol, A. A. (2011). Trends over time in the management of 2253 patients with cerebral aneurysms: A single practice experience. Surgical neurology international, 2110. https://doi.org/10.4103/2152-7806.83728
Payner, Troy D, et al. "Trends over time in the management of 2253 patients with cerebral aneurysms: A single practice experience." Surgical neurology international vol. 2 (2011): 110. doi: https://doi.org/10.4103/2152-7806.83728
Payner TD, Melamed I, Ansari S, Leipzig TJ, Scott JA, Denardo AJ, Horner TG, Redelman K, Cohen-Gadol AA. Trends over time in the management of 2253 patients with cerebral aneurysms: A single practice experience. Surg Neurol Int. 2011;2:110. doi: 10.4103/2152-7806.83728. Epub 2011 Aug 13. PMID: 21886883; PMCID: PMC3162800.
Copy Download .nbib Format: NLM
Thrombin antithrombin complex and IL-18 serum levels in stroke patients.

Neurology international

Piazza O, Scarpati G, Cotena S, Lonardo M, Tufano R.
PMID: 21577333
Neurol Int. 2010 Jun 21;2(1):e1. doi: 10.4081/ni.2010.e1.

The complex picture of inflammation and coagulation alterations comes to life in acute stroke phases. Increasing evidence points to a strong interaction and extensive crosstalk between the inflammation and coagulation systems: the interest towards this relationship has increased since...

Cite
Piazza O, Scarpati G, Cotena S, et al. Thrombin antithrombin complex and IL-18 serum levels in stroke patients. Neurol Int. 2010;2(1):e1doi: 10.4081/ni.2010.e1.
Piazza, O., Scarpati, G., Cotena, S., Lonardo, M., & Tufano, R. (2010). Thrombin antithrombin complex and IL-18 serum levels in stroke patients. Neurology international, 2(1), e1. https://doi.org/10.4081/ni.2010.e1
Piazza, Ornella, et al. "Thrombin antithrombin complex and IL-18 serum levels in stroke patients." Neurology international vol. 2,1 (2010): e1. doi: https://doi.org/10.4081/ni.2010.e1
Piazza O, Scarpati G, Cotena S, Lonardo M, Tufano R. Thrombin antithrombin complex and IL-18 serum levels in stroke patients. Neurol Int. 2010 Jun 21;2(1):e1. doi: 10.4081/ni.2010.e1. PMID: 21577333; PMCID: PMC3093205.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 330 entries